Board Of Pharmacy
Drug compounding under scrutiny - Pharmacy Watch - By the California Board of Pharmacy - Brief Article SACRAMENTO, Calif. -- Tougher standards impacting pharmacies that maintain their own compounding practices are likely to emerge by early next year as state lawmakers mull new legislation to boost oversight of compounding practices.
The new regulations should be up for review this fall by the California Board of Pharmacy, according to a report in the Contra Costa Times. Those new regulations, if adopted, will boost state inspections of compounding pharmacies and require additional, secondary licensing procedures for those practice sites.
The push for tougher standards came in the wake of a deadly incident last summer at Doc's Pharmacy, an independent pharmacy in Walnut Creek, Calif. In that incident, improper sterilization procedures in the compounding of an injectable steroid led to an outbreak of meningitis and the deaths of two patients, as well as the suicide of a Doc's co-owner, according to the report.
In a related development, the Food and Drug Administration last month also issued a new, more stringent set of guidelines for drug compounding.
COPYRIGHT 2002 Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
COPYRIGHT 2002 Gale Group
|
